FDA DrugClass IINotable

FDA Recall: CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi US

Date: 2026-04-01
Brand: Chiesi USA, Inc.
Category: Drug
FDA Class: Class II

Description

Lack of Assurance of Sterility

Hazard

Lack of Assurance of Sterility

Remedy

7,235 vials

Related Recalls